ZEB2 and myeloproliferative disorder: Interestingly, CXCR4 is the effector of ZEB2 in some hematopoietic cells [125], and genetic ablation of ZEB2 in hematopoietic lineage resulted in an increase in HSC and progenitors in the bone marrow and other specific features resembling myeloproliferative diseases in humans [126].